Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient

Demirci U., COŞKUN U., ERDEM Ö., Ozturk B., YILMAZ İ., BENEKLİ M., ...Daha Fazla

Journal of Oncology Pharmacy Practice, cilt.17, sa.3, ss.285-287, 2011 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 3
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1177/1078155210374674
  • Dergi Adı: Journal of Oncology Pharmacy Practice
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.285-287
  • Anahtar Kelimeler: acne rosacea, imatinib mesylate, sunitinib, tyrosine kinase inhibitors
  • Gazi Üniversitesi Adresli: Evet

Özet

Tyrosine kinase inhibitors (TKIs) are targeted treatments for various cancers. Skin toxicities are one of the most common nonhematological side-effects of TKIs. We report an imatinib mesylate (IM) induced hyperpigmented acne rosacea (AR) and sunitinib-induced palmar hyperkeratosis in the case with gastrointestinal stromal tumor. AR was arisen due to the discontinuation of IM. To the best of our knowledge, this kind of cutaneous side-effect with IM has not been documented previously. © The Author(s) 2010.